XML 25 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity Share-based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Stock Appreciation Rights (SARs) [Member]
Dec. 31, 2012
Stock Appreciation Rights (SARs) [Member]
Sep. 30, 2013
Restricted Stock [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2013
Restricted Stock [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2013
Restricted Stock [Member]
12 months or less [Member]
Sep. 30, 2013
Restricted Stock [Member]
Two to three years [Member]
Sep. 30, 2013
Restricted Stock [Member]
Three to four years [Member]
Sep. 30, 2013
Restricted Stock [Member]
Four to five years [Member]
Sep. 30, 2013
Restricted Stock [Member]
Five years or more [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Share-based incentive plan, number of shares authorized for issuance 2,500,000   2,500,000                        
Share-based incentive plan, number of shares remaining for issuance 1,550,118   1,550,118                        
Total share-based compensation expense $ 612 $ 490 $ 1,726 $ 1,410                      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options                              
Restricted stock outstanding at beginning of the period             526,803 454,117 448,283 365,506          
Restricted stock granted during the period             0 0 255,158 220,821          
Restricted stock vested during the period             (2,917) (2,917) (179,555) (135,127)          
Restricted stock outstanding at end of the period             523,886 451,200 523,886 451,200          
Stock Issued During Period, Value, Restricted Stock Award, Gross                 2,708 2,073          
Nonvested restricted stock, fair value remaining to be amortized             3,951   3,951   640 1,643 1,155 447 0
Stock Appreciation Rights [Roll Forward]                              
Stock appreciation rights outstanding at end of period         25,000                    
Stock appreciation rights outstanding at end of period, weighted average exercise price         $ 7.06                    
Stock appreciation rights, fair value of liability remaining         $ 0 $ 0